GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DNA Group (TR) Ltd (XTAE:DNA) » Definitions » Valuation Rank

DNA Group (TR) (XTAE:DNA) Valuation Rank


View and export this data going back to 2007. Start your Free Trial

What is DNA Group (TR) Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


DNA Group (TR) Valuation Rank Related Terms

Thank you for viewing the detailed overview of DNA Group (TR)'s Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


DNA Group (TR) (XTAE:DNA) Business Description

Traded in Other Exchanges
N/A
Address
Shimon Hatirsi Street 43, Tel Aviv, ISR, 62492
Website
DNA Group (TR) Ltd invests in biomed companies and has also started to engage in profitable real estate in England.